Search Results
Sep 10, 2026, 09:00 ET Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical Research
/PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that 10x Genomics, Inc. (Nasdaq: TXG) will incorporate Lunit's AI-powered pathology platform, Lunit SCOPE IO, into its oncology biomarker discovery workflow. Lunit SCOPE IO will be used
More news about: Lunit
Aug 28, 2026, 14:38 ET 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
challengePLEASANTON, Calif., Aug. 28, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the U.S. District Court
More news about: 10x Genomics, Inc.
Aug 11, 2026, 12:32 ET The Wimbledon Court comes to Central Park: Five Years of Wimbledon in New York City
Experiential Group (TXG)TXG is a full-service experiential marketing agency with a simple mission: create extraordinary experiences for clients, consumers, and colleagues. Specializing in large-scale brand activations, cultural events, and immersive fan experiences, TXG partners with the world's
More news about: The Experiential Group
Aug 06, 2026, 16:02 ET 10x Genomics Reports Second Quarter 2026 Financial Results
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today reported financial results for the second quarter
More news about: 10x Genomics, Inc.
Jul 29, 2026, 09:00 ET 10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Lausanne
More news about: 10x Genomics, Inc.
Jul 15, 2026, 16:05 ET 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, announced it will report financial results for the second
More news about: 10x Genomics, Inc.
Jun 17, 2026, 09:00 ET 10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Cleveland
More news about: 10x Genomics, Inc.
Jun 09, 2026, 09:00 ET 10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the acquisition of Proteintech Genomics,
More news about: 10x Genomics, Inc.
May 07, 2026, 16:05 ET 10x Genomics Reports First Quarter 2026 Financial Results
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2026.
More news about: 10x Genomics, Inc.
Apr 29, 2026, 16:05 ET 10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the BofA Securities
More news about: 10x Genomics, Inc.
Apr 29, 2026, 09:00 ET The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
(NASDAQ: SENS), TransMedics Group (NASDAQ: TMDX), WELL Health Technologies (TSX: WELL) (OTCQX: WHTCF), and 10x Genomics (NASDAQ: TXG).
More news about: Equity Insider
Apr 18, 2026, 22:00 ET 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome
More news about: 10x Genomics, Inc.
Apr 15, 2026, 16:05 ET 10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ended March 31, 2026 after market close
More news about: 10x Genomics, Inc.
Mar 25, 2026, 07:00 ET Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
10x Genomics, Inc. (Nasdaq: TXG) and
More news about: Bioptimus
Mar 25, 2026, 07:00 ET Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
10x Genomics, Inc. (Nasdaq: TXG) and
More news about: Bioptimus
Mar 17, 2026, 08:00 ET PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
Zheng, Ph.D., co-founder and CEO of PerturbAI.PerturbAI collaborated with NVIDIA, the Allen Institute for Brain Science, and 10x Genomics (Nasdaq: TXG) to generate and analyze the atlas, which enables systematic evaluation of the brain genome, providing a framework to distinguish causal mechanisms from
More news about: PerturbAI
Feb 19, 2026, 16:05 ET 10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen
More news about: 10x Genomics, Inc.
Feb 12, 2026, 16:05 ET 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided
More news about: 10x Genomics, Inc.
Feb 04, 2026, 09:00 ET PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that
More news about: 10x Genomics, Inc.
Jan 22, 2026, 16:05 ET 10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2025
More news about: 10x Genomics, Inc.
Jan 12, 2026, 09:11 ET 10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center,
More news about: 10x Genomics, Inc.
Jan 12, 2026, 09:10 ET 10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber Cancer Institute to analyze tumor samples from patients
More news about: 10x Genomics, Inc.
Jan 12, 2026, 09:00 ET Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with the Cancer Research Institute (CRI) to advance the frontiers of immuno-oncology
More news about: 10x Genomics, Inc.
Jan 11, 2026, 12:00 ET 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December
More news about: 10x Genomics, Inc.
Dec 29, 2025, 16:05 ET 10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 44th Annual J.P. Morgan
More news about: 10x Genomics, Inc.